ADXS-503
- Generic Name
- ADXS-503
Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer
Phase 1
Completed
- Conditions
- Lung Cancer, Non-Small CellMetastatic Squamous Cell CarcinomaMetastatic Non-Squamous Cell Carcinoma
- Interventions
- First Posted Date
- 2019-02-20
- Last Posted Date
- 2024-06-04
- Lead Sponsor
- Advaxis, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT03847519
- Locations
- 🇺🇸
City of Hope, Duarte, California, United States
🇺🇸Atlantic Health System, Carol G Simon Cancer Center, Morristown, New Jersey, United States
🇺🇸Illinois CancerCare, P.C., Peoria, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath